Mercedes Unzeta
Barcelona, CT 08193, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: February 21, 2021
Sensing of nutrients by CPT1C controls SAC1 activity to regulate AMPA receptor trafficking.
Journal: The Journal of cell biology
Published: December 09, 2019
Proteasomal-Mediated Degradation of AKAP150 Accompanies AMPAR Endocytosis during cLTD.
Journal: eNeuro
Published: June 06, 2019
Synthesis, biological evaluation, and molecular modeling of nitrile-containing compounds: Exploring multiple activities as anti-Alzheimer agents.
Journal: Drug development research
Published: April 19, 2019
Uric acid treatment after stroke modulates the Krüppel-like factor 2-VEGF-A axis to protect brain endothelial cell functions: Impact of hypertension.
Journal: Biochemical pharmacology
Published: January 18, 2019
Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: November 20, 2018
Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: October 04, 2017
Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: July 25, 2017
In-vitro and in-vivo evaluation of the modulatory effects of the multitarget compound ASS234 on the monoaminergic system.
Journal: The Journal of pharmacy and pharmacology
Published: September 26, 2016
The proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease.
Journal: Journal of psychiatry & neuroscience : JPN
Published: September 17, 2016
Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases.
Journal: Frontiers in neuroscience
Published: July 31, 2016
Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors.
Journal: Bioorganic & medicinal chemistry
Published: June 09, 2016
Last Updated: 09/26/2026